Radiesse 0.8: Professional Reconstitution and Handling Guide

Radiesse 0.8, manufactured by Merz in the USA, is a calcium hydroxylapatite (CaHA) microsphere biostimulator designed for professional aesthetic applications. It is supplied as a sterile, non-pyrogenic, semi-solid, cohesive, and fully biodegradable implant. Its formulation is tailored to support sustained collagen stimulation and improved skin quality. Understanding its composition and intended use is foundational for proper handling and preparation within a professional clinic setting.

Radiesse 0.8 is typically supplied in pre-filled syringes within sterile packaging. Upon receipt, professionals should inspect all packaging for integrity and verify lot numbers and expiry dates. Unopened Radiesse 0.8 syringes must be stored at controlled room temperature, generally between 15°C to 30°C (59°F to 86°F), protected from freezing and excessive heat. Maintaining proper storage conditions is crucial for preserving the product's stability and efficacy prior to Radiesse 1.5 or 0.8 preparation.

The reconstitution of Radiesse 0.8 involves diluting the product with an appropriate sterile diluent, most commonly 0.9% sodium chloride for injection. Some protocols may also incorporate sterile lidocaine solution to manage patient comfort during application. The goal of reconstitution is to achieve a homogenous suspension suitable for the intended application method. Precision in diluent volume and gentle, consistent mixing are paramount to ensure the uniform distribution of CaHA microspheres and maintain product integrity. This process is similar in principle to other biostimulators available for professional sourcing, such as Sculptra (2 vials).

Different dilution ratios for Radiesse 0.8 are referenced in professional literature to achieve varying rheological properties, suitable for distinct aesthetic application approaches. For skin revitalization and biostimulation, common dilution ratios for Radiesse 0.8 range from 1:1 to 1:2 (product:diluent). For example, a 1:1 dilution would involve mixing 0.8 mL of Radiesse with 0.8 mL of diluent. A 1:2 dilution would involve 0.8 mL of Radiesse with 1.6 mL of diluent. These ratios modify the product's viscosity and spreadability, influencing its behavior within tissues. Practitioners should adhere strictly to established protocols and manufacturer guidelines regarding specific diluents and volumes.

Once Radiesse 0.8 has been reconstituted, it must be used promptly. The manufacturer typically specifies a limited shelf life for the prepared suspension, often within a few hours, to maintain sterility and product characteristics. Any unused reconstituted product should be discarded in accordance with local biohazard waste disposal regulations. Maintaining aseptic technique throughout the entire preparation and application process is non-negotiable for patient safety and product integrity. This focus on meticulous handling applies to all injectables, including other skinbooster / biostimulator catalog items.

Sourcing authentic Radiesse 0.8 is critical for professional practice integrity and patient safety. Distributors should provide verifiable lot numbers, ensure cold chain maintenance, and offer certificates of authenticity. Professionals should always procure products from reputable wholesale channels to prevent counterfeit or improperly handled inventory. Understanding the regulatory status of aesthetic products is also vital for compliance, a topic further explored in our guide on Tesoro Filler: Understanding Regulatory Status for Professio.